Collplant Ebit Per Revenue from 2010 to 2024

CLGN Stock  USD 5.95  0.24  3.88%   
Collplant Biotechnologies Ebit Per Revenue yearly trend continues to be very stable with very little volatility. Ebit Per Revenue is likely to drop to -0.72. During the period from 2010 to 2024, Collplant Biotechnologies Ebit Per Revenue quarterly data regression pattern had sample variance of  2,113 and median of (57.18). View All Fundamentals
 
Ebit Per Revenue  
First Reported
2010-12-31
Previous Quarter
(0.69)
Current Value
(0.72)
Quarterly Volatility
45.96206113
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Collplant Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Collplant main balance sheet or income statement drivers, such as Depreciation And Amortization of 878.7 K, Interest Expense of 9.5 K or Selling General Administrative of 3.8 M, as well as many exotic indicators such as Price To Sales Ratio of 6.31, Dividend Yield of 0.0 or PTB Ratio of 2.44. Collplant financial statements analysis is a perfect complement when working with Collplant Biotechnologies Valuation or Volatility modules.
  
This module can also supplement Collplant Biotechnologies' financial leverage analysis and stock options assessment as well as various Collplant Biotechnologies Technical models . Check out the analysis of Collplant Biotechnologies Correlation against competitors.
To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.

Latest Collplant Biotechnologies' Ebit Per Revenue Growth Pattern

Below is the plot of the Ebit Per Revenue of Collplant Biotechnologies over the last few years. It is Collplant Biotechnologies' Ebit Per Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Collplant Biotechnologies' overall financial position and show how it may be relating to other accounts over time.
Ebit Per Revenue10 Years Trend
Slightly volatile
   Ebit Per Revenue   
       Timeline  

Collplant Ebit Per Revenue Regression Statistics

Arithmetic Mean(49.09)
Geometric Mean9.11
Coefficient Of Variation(93.62)
Mean Deviation43.30
Median(57.18)
Standard Deviation45.96
Sample Variance2,113
Range94.3363
R-Value0.81
Mean Square Error775.75
R-Squared0.66
Significance0.0002
Slope8.34
Total Sum of Squares29,575

Collplant Ebit Per Revenue History

2024 -0.72
2023 -0.69
2022 -57.18
2021 0.004156
2020 -0.91
2019 -3.29
2018 -0.85

About Collplant Biotechnologies Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Collplant Biotechnologies income statement, its balance sheet, and the statement of cash flows. Collplant Biotechnologies investors use historical funamental indicators, such as Collplant Biotechnologies's Ebit Per Revenue, to determine how well the company is positioned to perform in the future. Although Collplant Biotechnologies investors may use each financial statement separately, they are all related. The changes in Collplant Biotechnologies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Collplant Biotechnologies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Collplant Biotechnologies Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Collplant Biotechnologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Ebit Per Revenue(0.69)(0.72)
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Collplant Biotechnologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Collplant Biotechnologies' short interest history, or implied volatility extrapolated from Collplant Biotechnologies options trading.

Pair Trading with Collplant Biotechnologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Collplant Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collplant Biotechnologies will appreciate offsetting losses from the drop in the long position's value.

Moving against Collplant Stock

  0.74BMY Bristol Myers Squibb Earnings Call This WeekPairCorr
  0.52EW Edwards Lifesciences Corp Earnings Call This WeekPairCorr
  0.47ABBV AbbVie IncPairCorr
The ability to find closely correlated positions to Collplant Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Collplant Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Collplant Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Collplant Biotechnologies to buy it.
The correlation of Collplant Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Collplant Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Collplant Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Collplant Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Collplant Biotechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Collplant Biotechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Collplant Biotechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Collplant Biotechnologies Stock:
Check out the analysis of Collplant Biotechnologies Correlation against competitors.
To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.
Note that the Collplant Biotechnologies information on this page should be used as a complementary analysis to other Collplant Biotechnologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Collplant Stock analysis

When running Collplant Biotechnologies' price analysis, check to measure Collplant Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Collplant Biotechnologies is operating at the current time. Most of Collplant Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Collplant Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Collplant Biotechnologies' price. Additionally, you may evaluate how the addition of Collplant Biotechnologies to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Is Collplant Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collplant Biotechnologies. If investors know Collplant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collplant Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.62)
Revenue Per Share
0.962
Quarterly Revenue Growth
4.155
Return On Assets
(0.13)
Return On Equity
(0.23)
The market value of Collplant Biotechnologies is measured differently than its book value, which is the value of Collplant that is recorded on the company's balance sheet. Investors also form their own opinion of Collplant Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Collplant Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collplant Biotechnologies' market value can be influenced by many factors that don't directly affect Collplant Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collplant Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Collplant Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collplant Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.